A Clue to Better Select Chronic Lymphocytic Leukemia Patients with Optimal Response to BNT162b2 mRNA COVID-19 Vaccine

Given the immunosuppression of chronic lymphocytic leukemia (CLL), this disease represents a challenging model for assessing the extent of serologic response to mRNA vaccination against severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). In this perspective, we assessed the efficacy of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Molica, Stefano, Giannarelli, Diana, Lentini, Mirella, Zappala, Daniela, Loiacono, Daniela, Gianfelici, Valentina, Panduri, Giuseppina, Minchella, Pasquale, Talarico, Francesco, Levato, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
642.Chronic Lymphocytic Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701679/
http://dx.doi.org/10.1182/blood-2021-149104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701679/
http://dx.doi.org/10.1182/blood-2021-149104

Ejemplares similares